Connect Biopharma Holdings (CNTB) Equity Ratio (2023 - 2025)
Connect Biopharma Holdings (CNTB) has disclosed Equity Ratio for 3 consecutive years, with 0.75 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 17.73% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, down 17.73% year-over-year, with the annual reading at 0.75 for FY2025, 17.73% down from the prior year.
- Equity Ratio hit 0.75 in Q4 2025 for Connect Biopharma Holdings, down from 0.82 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.91 in Q4 2024 to a low of 0.75 in Q4 2025.
- Historically, Equity Ratio has averaged 0.84 across 3 years, with a median of 0.84 in 2025.
- Biggest five-year swings in Equity Ratio: increased 14.2% in 2024 and later decreased 17.73% in 2025.
- Year by year, Equity Ratio stood at 0.8 in 2023, then increased by 14.2% to 0.91 in 2024, then fell by 17.73% to 0.75 in 2025.
- Business Quant data shows Equity Ratio for CNTB at 0.75 in Q4 2025, 0.82 in Q3 2025, and 0.86 in Q2 2025.